Public Relations

Overseas investors buy Rs 994 crore of stocks

Overseas funds bought a net Rs 994 crore ($213 million) of Indian equities yesterday, taking their investments in stocks this year to Rs 77,410 crore, the nation’s market regulator said today. - Sebi asks bourses to preserve papers for five years - SEBI asks bourses to save records till probe is over - Need special bourses for small, medium firms: Pranab - IL&FS Transportation qualifies for Rs 16k cr projs - Nitesh Estates hopes to raise Rs 450 cr via IPO - Baroda Pioneer eyes Rs 5,000 cr AUM Investors acquired Rs 2,870 crore of shares and sold Rs 1,880 crore, the Securities and Exchange Board of India said today. They placed a net Rs 8,160 crore in bonds. Purchases by global investors have reached $16.6 billion this year, approaching the record $17.2 billion of net inflow into stocks in 2007. That’s fueled a 78 per cent advance in the benchmark Sensitive Index this year, with the index poised for the biggest annual gain in 18 years. The funds bought a net Rs 6,900 crore of debt this year, compared with Rs 11,800 crore in 2008. Overseas funds have placed $71.8 billion in Indian equities since they were allowed into the country in 1993. They withdrew a record Rs 53,000 crore in 2008, triggering the biggest annual decline on record. The regulator provides data on shares bought and sold by big investors, including trades in the primary and secondary markets, with a delay of at least a day.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Govt to soon resolve FDI norms in Indian banks
The issue concerning foreign ownership in Indian banks is currently under discussion among the finance ministry, commerce and industry ministry and the Reserve Bank of India (RBI) and is likely to be resolved soon.
Popular Articles

DHFL net at Rs 37 crore
Dewan Hosing Finance Limited (DHFL) reported 69.96 per cent increase in its net profit at Rs 37.51 crore for the quarter ended September 30, 2009 as compared Rs 22.7 crore in the corresponding quarter last year.

Pfizer to source 40 off-patent cancer care drugs from Strides
Global pharma major Pfizer is to source source 40 off-patent (generic) cancer care products from Bangalore-based Strides Arcolab and sell the products in the United States.